Building the future of individualised medicines
We are in a unique time where we now have the technology to find patients with genetic conditions and design medicines to treat them - giving patients and their families a chance at a longer, healthier life together. However, this is increasingly requiring customisation of medicines to very small groups of patients, even to just one, something our current system of population-focused medicine was never designed for.
OUR MISSION
The Rare Therapies Launch Pad (RTLP) was established in the UK to model a scalable and sustainable system to meet the new era of individualised medicines, focused on putting in place an innovative regulatory and reimbursement end-to-end pathway to allow for rapid access to cutting-edge science by anyone who could benefit.